This carrier system could deliver siCOX-2 into the cytoplasm of HepG2 cells irreversibly to inhibit COX-2 expression and its downstream pathway so as to control the growth and metastasis of tumor cells. This evidence concerns the gene PTGS2 and neoplasm.